Beaumont Financial Partners, LLC Biogen Inc. Transaction History

Beaumont Financial Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$223.92 - $287.77 $188,316 - $242,014	-841 Closed	0 $0
Q2 2021 Aug 04, 2021	BUY	$259.0 - $414.71 $27,195 - $43,544	105 Added 14.27%	841 $291,000
Q1 2021 May 04, 2021	BUY	$242.95 - $284.63 $178,811 - $209,487	736 New	736 $206,000
Q4 2020 Feb 08, 2021	SELL	$236.26 - $355.63 $205,782 - $309,753	-871 Closed	0 $0
Q3 2020 Nov 02, 2020	BUY	$264.77 - $305.71 $230,614 - $266,273	871 New	871 $247,000
Q2 2020 Aug 05, 2020	SELL	$258.66 - $342.55 $220,895 - $292,537	-854 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$268.85 - $341.04 $6,183 - $7,843	23 Added 2.77%	854 $270,000
Q4 2019 Feb 06, 2020	BUY	$220.06 - $304.07 $182,869 - $252,682	831 New	831 $247,000

1,032

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Beaumont Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Beaumont Financial Partners, LLC with notifications on news.